Alterity Therapeutics Inc. (ATHE) stock fell during pre-market. What’s behind this downfall?
Alterity Therapeutics Inc. (NASDAQ: ATHE) stock gained by 7.91% at last close whereas the ATHE stock price declines by 3.33% in the pre-market trading session. Alterity Therapeutics is a clinical-stage biotech firm devoted to a better future for those suffering from neurodegenerative disorders. ATH434 which is ATHE’s main asset, has the potential to treat a […]
Alterity Therapeutics Ltd. (ATHE) stock plunged during pre-market trading. Here’s the recent update
Alterity Therapeutics Ltd. (NASDAQ: ATHE) stock gained by 64.62% at last close whereas the ATHE stock-price declines by 9.35% in the pre-market trading session. Alterity is working on first-in-class neurodegenerative disease treatments. ATH434, their main medication candidate, has shown effectiveness in many animal models of Parkinson’s disease and is currently being tested in human studies. […]
